New 9-Month pill regimen could revolutionize Drug-Resistant TB treatment
Disease control
Not yet recruiting
This study tests a new all-oral, 9-month treatment called BLMZ for people with rifampicin-resistant tuberculosis (TB). About 120 participants aged 12 and older in China will take the pills and be monitored for 24 months. The goal is to see if this shorter regimen works as well as…
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC